Novartis to exit Indian unit in $159 million deal
Image used for illustration purpose only.
| Photo Credit: Reuters
Swiss drugmaker Novartis said on Friday (February 20, 2026) it would sell its entire 70.68% stake in its listed Indian unit for ₹14.46 billion ($159 million).
The stake will be acquired by a consortium of WaveRise Investments, ChrysCapital and Two Infinity Partners.
The companies have also made an offer to purchase an additional 26% stake from Novartis India’s public shareholders, under takeover regulations that mandate such an exercise on purchase of a shareholding of over 25%.
The consortium will offer Novartis India’s public shareholders 860.64 rupees per share, an exchange filing showed, representing a 3.6% premium to its closing price on Thursday.
Published – February 20, 2026 09:23 am IST
